Invention Grant
- Patent Title: Compositions and methods for modifying cells
-
Application No.: US15603014Application Date: 2017-05-23
-
Publication No.: US10344299B2Publication Date: 2019-07-09
- Inventor: Aris N. Economides , Andrew J. Murphy , David M. Valenzuela , David Frendewey , George D. Yancopoulos
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Foley Hoag LLP
- Main IPC: C12N15/85
- IPC: C12N15/85 ; A01K67/027 ; C12N15/90 ; C12N15/79 ; C12Q1/6827 ; C12N5/0735

Abstract:
A method for engineering and utilizing large DNA vectors to target, via homologous recombination, and modify, in any desirable fashion, endogenous genes and chromosomal loci in eukaryotic cells. These large DNA targeting vectors for eukaryotic cells, termed LTVECs, are derived from fragments of cloned genomic DNA larger than those typically used by other approaches intended to perform homologous targeting in eukaryotic cells. Also provided is a rapid and convenient method of detecting eukaryotic cells in which the LTVEC has correctly targeted and modified the desired endogenous gene(s) or chromosomal locus (loci) as well as the use of these cells to generate organisms bearing the genetic modification.
Public/Granted literature
- US20170260544A1 Compositions and Methods for Modifying Cells Public/Granted day:2017-09-14
Information query
IPC分类: